Four essential generic medicines for HIV treatment were assessed and recommended for sale in May by the Caribbean Regulatory System (CRS) in one of its first actions advising government on medicines regulation in Caricom.
According to a media release from Pan American Health Organisation/World Health Organisation (PAHO/WHO), the Caribbean Public health Agency (Carpha)/ CRS recommended manufacturer’s versions of four products, including Emtricitibine/Tenofovir and Tenofovir tablets, used in treatment of HIV. The regional initiative to help Caribbean states perform key regulatory functions is a collaboration between Caricom and Carpha, with the support of PAHO/WHO.
The PAHO/WHO release said that the states of Caricom can be individually